The U.S. Department of Justice (DOJ) has filed a civil antitrust lawsuit against OhioHealth Corporation, alleging the central Ohio healthcare system is leveraging its market dominance to inflate healthcare costs for patients. The lawsuit, filed February 20, 2026, in the U.S. District Court for the Southern District of Ohio, contends that OhioHealth’s contractual restrictions with insurers limit competition and prevent consumers from accessing more affordable healthcare options. This action underscores a growing federal focus on healthcare market consolidation and its impact on affordability, a priority highlighted by Attorney General Pamela Bondi.
The core of the DOJ’s argument centers on OhioHealth’s alleged practice of requiring insurers to include all of its facilities in their networks. This “all-or-nothing” approach, according to the complaint, effectively prevents insurers from offering plans that exclude OhioHealth hospitals, even if those plans would be cheaper for consumers. The lawsuit alleges that this lack of competitive pressure allows OhioHealth to charge significantly higher prices for its services than other healthcare providers in the Columbus metropolitan area, without a corresponding improvement in quality of care. The issue of rising healthcare costs remains a critical concern for Americans, and this case represents a significant attempt to address anticompetitive practices within the industry.
OhioHealth’s Market Position and the Antitrust Concerns
OhioHealth is the largest healthcare system in central Ohio, operating 16 hospitals alongside numerous outpatient facilities, physician groups, and other clinics. According to the DOJ, the system controls more than 35% of inpatient acute care hospital beds in the Columbus metropolitan market. This substantial market share, confirmed by a Fitch Ratings assessment, is “notably greater” than that of its competitors, including Ohio State University Wexner Medical Center and Trinity Health-owned Mount Carmel Health System. Fitch Ratings affirmed OhioHealth’s credit rating in October 2025, noting its strong market position.
The DOJ argues that OhioHealth’s dominant position gives it undue leverage in negotiations with insurance companies. Since of its size and extensive network, insurers are compelled to include OhioHealth facilities in their plans to ensure patients have adequate access to care. This, in turn, diminishes competition, as OhioHealth isn’t incentivized to lower prices or improve quality to attract patients. The department contends that this stifles the “virtuous cycle” of competition, where providers are driven to offer better value to consumers. Acting Assistant Attorney General Omeed A. Assefi of the DOJ’s Antitrust Division emphasized that “competition for healthcare is vital to all Americans,” and that these restrictions lead to higher costs for Columbus residents.
The Alleged Impact on Consumers and Insurers
The lawsuit specifically targets OhioHealth’s contractual restrictions, which the DOJ claims prevent commercial health insurance companies from offering lower-cost plans to patients. Typically, insurers offer a range of plans with varying price points, based on the breadth of the provider network. Consumers can choose plans with broader networks – and higher premiums – or opt for more restrictive networks with lower costs. By forcing insurers to include all OhioHealth providers, the system effectively eliminates the possibility of offering plans that exclude its facilities, limiting consumer choice and driving up prices.
The financial implications of OhioHealth’s practices are significant. The DOJ alleges that OhioHealth charges substantially more for healthcare services compared to other systems in the Columbus area, without demonstrable improvements in quality. This translates to higher out-of-pocket costs for patients, increased premiums for employers, and a strain on the overall healthcare system. The lack of price transparency makes it challenging for consumers to shop for the best value, exacerbating the problem. The lawsuit seeks to enjoin OhioHealth from enforcing these anticompetitive contractual terms and to restore competition in the central Ohio healthcare market.
OhioHealth’s Response and the Broader Context
OhioHealth has stated it is cooperating with the Justice Department and remains “committed to full compliance with all applicable laws and regulatory requirements.” A spokesperson for the health system declined to comment on the specifics of the case. This lawsuit arrives amidst a period of increased scrutiny of hospital consolidation and its impact on healthcare costs. The DOJ’s action follows the recent firing of Gail Slater, the division’s Trump-appointed assistant attorney general, a week prior to the filing, replaced by Omeed Assefi, who is serving in an acting capacity. CBS News reported on the timing of Slater’s departure and its potential influence on the case.
Interestingly, OhioHealth has demonstrated strong financial performance in recent years. The system recorded a 10% operating margin with 548 days of cash on hand in its 2025 fiscal year, according to data from Emma MSMRB. Emma MSMRB provides detailed financial information on municipal bonds, including those issued by healthcare systems. This contrasts with the average nonprofit hospital, which had a 1.1% margin and approximately 215 days of cash on hand during the same period, as reported by Fitch Ratings. Fitch Ratings analysis highlights the financial disparities within the nonprofit hospital sector.
The Role of the Ohio Attorney General
The Justice Department is partnering with the Ohio Attorney General, Dave Yost, in this lawsuit. Yost’s office contends that OhioHealth uses its market strength to compel insurers to include its facilities in all commercial insurance networks, effectively preventing the offering of lower-priced health plans in central Ohio. The Ohio Attorney General’s office released a statement outlining their involvement and the shared goal of reducing healthcare costs for Ohio residents.
This collaborative effort between the federal government and the state of Ohio signals a unified front in addressing anticompetitive practices within the healthcare industry. The outcome of this case could have far-reaching implications, not only for OhioHealth and its patients but likewise for other healthcare systems across the country. It could set a precedent for future antitrust enforcement actions and encourage greater transparency and competition in the healthcare market.
The case is currently pending in the U.S. District Court for the Southern District of Ohio. The next scheduled action is a preliminary conference set for March 15, 2026, to discuss the procedural aspects of the case and establish a timeline for discovery and potential trial. Readers interested in following the case can access court filings and updates through the U.S. Courts website. We will continue to provide updates as this important case progresses. Share your thoughts on this developing story in the comments below.